Status:

COMPLETED

Mini-invasive Lumbar Arthrodesis in Ambulatory

Lead Sponsor:

Elsan

Conditions:

Lumbar Spine Degeneration

Eligibility:

All Genders

18-75 years

Phase:

NA

Brief Summary

Degenerative lumbar pathologies are characterised by functional impairment and the occurrence of severe chronic pain and disability Arthrodesis of the lumbar spine is a common surgery for the treatmen...

Detailed Description

Degenerative lumbar disease (DLD) is a condition of increasing frequency, affecting millions of patients worldwide. They are characterised by functional impairment and the occurrence of severe chronic...

Eligibility Criteria

Inclusion

  • Age between 18 and 75 years
  • Patients affiliated to a social security system.
  • Informed, dated and signed consent
  • ASA 1 or 2
  • Patient compliant and adhering to protocol visits
  • Indication for a 1-level mini-invasive lumbar arthrodesis performed by anterior or posterior approach
  • Failure of conservative treatment for more than 3 months

Exclusion

  • History of lumbar arthrodesis
  • Active neoplasia
  • History of osteoporotic fractures of the spine
  • Arthrodesis superior to 1 level
  • Intolerance or contraindication to morphine treatments
  • Respiratory insufficiency
  • Preoperative anticoagulant treatment
  • Contraindication to the ambulatory care: patient living alone at home, or at a distance from the establishment, and thus requiring a follow-up care and rehabilitation hospitalization
  • Patient with a body mass index of greater than 40 kg/m².
  • Patient with a fever (\>38°C)
  • Suspected or known allergy or intolerance to the materials used and requiring a combination of different metals.
  • Patient with a contraindication to the material used or for whom the use of the implant could interfere with their anatomical structures or expected physiological function.
  • Pregnant or breastfeeding women
  • Patient participating to an ongoing study that may interfere with the present study
  • Patient under legal protection

Key Trial Info

Start Date :

September 28 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 17 2021

Estimated Enrollment :

39 Patients enrolled

Trial Details

Trial ID

NCT04914728

Start Date

September 28 2020

End Date

December 17 2021

Last Update

November 21 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Unité de Chirurgie de la Colonne Vertébrale

Bruges, France, 33520